126 related articles for article (PubMed ID: 9601625)
1. Noncompliance may render migraine prophylaxis useless, but once-daily regimens are better.
Mulleners WM; Whitmarsh TE; Steiner TJ
Cephalalgia; 1998 Jan; 18(1):52-6. PubMed ID: 9601625
[TBL] [Abstract][Full Text] [Related]
2. [Current views on migraine and anti-migraine preparations].
Ignatov IuD; Skoromets AA; Amelin AV
Vestn Ross Akad Med Nauk; 2003; (10):13-9. PubMed ID: 14598505
[TBL] [Abstract][Full Text] [Related]
3. Weight variations in the prophylactic therapy of primary headaches: 6-month follow-up.
Maggioni F; Ruffatti S; Dainese F; Mainardi F; Zanchin G
J Headache Pain; 2005 Sep; 6(4):322-4. PubMed ID: 16362700
[TBL] [Abstract][Full Text] [Related]
4. Botulinum toxin type A as migraine preventive treatment in patients previously failing oral prophylactic treatment due to compliance issues.
Cady R; Schreiber C
Headache; 2008 Jun; 48(6):900-13. PubMed ID: 18047501
[TBL] [Abstract][Full Text] [Related]
5. Cyclandelate in the prophylaxis of migraine: a randomized, parallel, double-blind study in comparison with placebo and propranolol. The Study group.
Diener HC; Föh M; Iaccarino C; Wessely P; Isler H; Strenge H; Fischer M; Wedekind W; Taneri Z
Cephalalgia; 1996 Oct; 16(6):441-7. PubMed ID: 8902255
[TBL] [Abstract][Full Text] [Related]
6. Comparison of propranolol LA 80 mg and propranolol LA 160 mg in migraine prophylaxis: a placebo controlled study.
al-Qassab HK; Findley LJ
Cephalalgia; 1993 Apr; 13(2):128-31. PubMed ID: 8495455
[TBL] [Abstract][Full Text] [Related]
7. A double blind controlled study of propranolol and cyproheptadine in migraine prophylaxis.
Rao BS; Das DG; Taraknath VR; Sarma Y
Neurol India; 2000 Sep; 48(3):223-6. PubMed ID: 11025624
[TBL] [Abstract][Full Text] [Related]
8. Pizotifen once daily in the prophylaxis of migraine: results of a multi-centre general practice study.
Crowder D; Maclay WP
Curr Med Res Opin; 1984; 9(4):280-5. PubMed ID: 6391831
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of amitriptyline, pizotifen and propranolol in the prevention of migraine.
Israil A; Ahmed S; Rahman KM; Uddin MJ; Dey SK; Battacharjee M; Mondal G; Ali MA; Alam MN; Miah AH; Uddin MS
Mymensingh Med J; 2013 Jan; 22(1):93-100. PubMed ID: 23416816
[TBL] [Abstract][Full Text] [Related]
10. Patient compliance with once-daily and twice-daily oral formulations of 5-isosorbide mononitrate: a comparative study.
Brun J
J Int Med Res; 1994; 22(5):266-72. PubMed ID: 7867871
[TBL] [Abstract][Full Text] [Related]
11. If migraine prophylaxis does not work, think about compliance.
Steiner TJ; Catarci T; Hering R; Whitmarsh T; Couturier EG
Cephalalgia; 1994 Dec; 14(6):463-4. PubMed ID: 7697710
[TBL] [Abstract][Full Text] [Related]
12. A double-blind, randomized trial of low-dose topiramate vs propranolol in migraine prophylaxis.
Ashtari F; Shaygannejad V; Akbari M
Acta Neurol Scand; 2008 Nov; 118(5):301-5. PubMed ID: 18713156
[TBL] [Abstract][Full Text] [Related]
13. Responders and non-responders to metoprolol, propranolol and nifedipine treatment in migraine prophylaxis: a dose-range study based on time-series analysis.
Gerber WD; Diener HC; Scholz E; Niederberger U
Cephalalgia; 1991 Feb; 11(1):37-45. PubMed ID: 2036669
[TBL] [Abstract][Full Text] [Related]
14. The dose of propranolol for migraine prophylaxis. Efficacy of low doses.
Pascual J; Polo JM; Berciano J
Cephalalgia; 1989 Dec; 9(4):287-91. PubMed ID: 2611887
[TBL] [Abstract][Full Text] [Related]
15. Patterns of compliance with once versus twice daily antihypertensive drug therapy in primary care: a randomized clinical trial using electronic monitoring.
Leenen FH; Wilson TW; Bolli P; Larochelle P; Myers M; Handa SP; Boileau G; Tanner J
Can J Cardiol; 1997 Oct; 13(10):914-20. PubMed ID: 9374947
[TBL] [Abstract][Full Text] [Related]
16. Analysis of the duration of migraine prophylaxis.
Silva-Néto RP; Almeida KJ; Bernardino SN
J Neurol Sci; 2014 Feb; 337(1-2):38-41. PubMed ID: 24308946
[TBL] [Abstract][Full Text] [Related]
17. The DIACOM study (effect of DosIng frequency of oral Antidiabetic agents on the COMpliance and biochemical control of type 2 diabetes).
Kardas P
Diabetes Obes Metab; 2005 Nov; 7(6):722-8. PubMed ID: 16219016
[TBL] [Abstract][Full Text] [Related]
18. [Current state of knowledge and developments in the prophylaxis and acute treatment of migraine].
Schriever J; Bühlen M; Broich K
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2014 Aug; 57(8):974-82. PubMed ID: 25028243
[TBL] [Abstract][Full Text] [Related]
19. Do pizotifen or propranolol reduce the frequency of migraine headache?
Barnes N; Millman G
Arch Dis Child; 2004 Jul; 89(7):684-5. PubMed ID: 15210509
[No Abstract] [Full Text] [Related]
20. A systematic review of the associations between dose regimens and medication compliance.
Claxton AJ; Cramer J; Pierce C
Clin Ther; 2001 Aug; 23(8):1296-310. PubMed ID: 11558866
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
